José Bellver
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
José Bellver has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Pellicer
Department of Paediatrics, Obstetrics and Gynecology, University of Valencia
12 shared publications José Remohí
6 shared publications- Marcos Meseguer
IVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe)
4 shared publications Vicente Serra
Instituto Valenciano de Infertilidad (IVI) , University of Valencia , Plaza de la Policía Local, 3, 46015 Valencia , Spain
4 shared publicationsMarcos Ferrando
3 shared publicationsAlberto Ramírez
IVI México D.F. , Mexico
2 shared publications
Latest Publications
- 1 March 2018
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 36, e8
PGD-A in advanced maternal age: final results of a day-3 biopsy RCT
- 1 March 2018
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 36, e8
PGD-A in advanced maternal age: final results of a day-3 biopsy RCT
- 1 June 2011
- Published by Elsevier in Fertility and Sterility
- Vol. 95 (7) , 2335-2341.e8
Endometrial gene expression in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome
- 1 June 2011
- Published by Elsevier in Fertility and Sterility
- Vol. 95 (7) , 2335-2341.e8
Endometrial gene expression in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome
- 31 August 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 94 (3) , 1065-1071
GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controlled trial
- 31 August 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 94 (3) , 1065-1071
GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controlled trial
- Open Access
- 24 May 2010
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 25 (7) , 1713-1721
Y chromosome microdeletions, sperm DNA fragmentation and sperm oxidative stress as causes of recurrent spontaneous abortion of unknown etiology
The aim of the present study was to evaluate the implication of male factor, in terms of sperm DNA oxidation and fragmentation, and Y chromosome microdeletions in recurrent spontaneous abortion (RSA) of unknown origin in a strictly selected cohort. A prospective cohort study was carried out in a private university-affiliated setting. Three groups, each comprised of 30 males, were compared. The first was formed by healthy and fertile sperm donors (SD) with normal sperm parameters (control group), the second by men presenting severe oligozoospermia (SO) without RSA history, and the third by men from couples who had experienced idiopathic RSA. Frequency of Y chromosome microdeletions and mean sperm DNA fragmentation and oxidation were determined. Y chromosome microdeletions were not detected in any of the males enrolled in the study. Moreover, sperm DNA oxidation measurements were not demonstrated to be relevant to RSA. Interestingly, sperm DNA fragmentation was higher in the SO group than in the RSA and the SD groups, and also higher in the RSA group compared with the SD group, but lacked an adequate predictive power to be employed as a discriminative test of RSA condition. Sperm DNA features and Y chromosome microdeletions do not seem to be related to RSA of unknown origin. Other molecular features of sperm should be studied to determine their possible influence on RSA. Clinicaltrials.gov reference: nCT00447395.
- 24 May 2010
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 25 (7) , 1713-1721
Open AccessY chromosome microdeletions, sperm DNA fragmentation and sperm oxidative stress as causes of recurrent spontaneous abortion of unknown etiology
The aim of the present study was to evaluate the implication of male factor, in terms of sperm DNA oxidation and fragmentation, and Y chromosome microdeletions in recurrent spontaneous abortion (RSA) of unknown origin in a strictly selected cohort. A prospective cohort study was carried out in a private university-affiliated setting. Three groups, each comprised of 30 males, were compared. The first was formed by healthy and fertile sperm donors (SD) with normal sperm parameters (control group), the second by men presenting severe oligozoospermia (SO) without RSA history, and the third by men from couples who had experienced idiopathic RSA. Frequency of Y chromosome microdeletions and mean sperm DNA fragmentation and oxidation were determined. Y chromosome microdeletions were not detected in any of the males enrolled in the study. Moreover, sperm DNA oxidation measurements were not demonstrated to be relevant to RSA. Interestingly, sperm DNA fragmentation was higher in the SO group than in the RSA and the SD groups, and also higher in the RSA group compared with the SD group, but lacked an adequate predictive power to be employed as a discriminative test of RSA condition. Sperm DNA features and Y chromosome microdeletions do not seem to be related to RSA of unknown origin. Other molecular features of sperm should be studied to determine their possible influence on RSA. Clinicaltrials.gov reference: nCT00447395.
- 1 January 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (2) , 447-454
Female obesity impairs in vitro fertilization outcome without affecting embryo quality
- 1 January 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (2) , 447-454
Female obesity impairs in vitro fertilization outcome without affecting embryo quality
- 1 January 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (1) , 270-271
Blood group and ovarian hyperstimulation syndrome
- 1 January 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (1) , 270-271
Blood group and ovarian hyperstimulation syndrome
- 1 December 2009
- Published by Elsevier in Fertility and Sterility
- Vol. 92 (6) , 1803-1810
Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome
- 1 December 2009
- Published by Elsevier in Fertility and Sterility
- Vol. 92 (6) , 1803-1810
Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome
- 31 January 2008
- Published by Elsevier in Fertility and Sterility
- Vol. 89 (1) , 141-150
Human immunodeficiency type-1 virus (HIV-1) infection in serodiscordant couples (SDCs) does not have an impact on embryo quality or intracytoplasmic sperm injection (ICSI) outcome
- 31 January 2008
- Published by Elsevier in Fertility and Sterility
- Vol. 89 (1) , 141-150
Human immunodeficiency type-1 virus (HIV-1) infection in serodiscordant couples (SDCs) does not have an impact on embryo quality or intracytoplasmic sperm injection (ICSI) outcome
- 1 January 2008
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 17 (5) , 595-604
Influence of paternal age on assisted reproduction outcome
- 1 January 2008
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 17 (5) , 595-604
Influence of paternal age on assisted reproduction outcome
- Open Access
- 10 December 2007
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 23 (2) , 278-284
The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion
The role of thrombophilia and thyroid autoimmunity in unexplained infertility (UI), implantation failure (IF) and recurrent spontaneous abortion (RSA) is controversial and poorly understood. From March, 2004 to January, 2007, 119 women were prospectively included: 32 oocyte donors, 31 patients with UI, 26 with IF and 30 with RSA. The IF and RSA groups presented normal preimplantation genetic screening. Protein C, protein S, antithrombin III, lupus anticoagulant, activated protein C resistance (APCR), immunoglobulin M and G anticardiolipin antibodies, homocystine, Factor V Leiden, prothrombin G20210A mutation, methylentetrahydrofolate reductase C677T mutation, thyroid-stimulating hormone (TSH), free thyroxine, anti-thyroid peroxidase (TPO) and anti-thyroglobulin (TG) antibodies were assessed. The prevalence of thrombophilia was high and similar among groups. In the IF group, the prevalence of APCR (15.4%), lupus anticoagulant (11.5%) and combined thrombophilia (19.2%) was higher, but not significantly different, than the other three groups. The prevalence of thyroid autoimmunity in women with IF (anti-TPO antibodies, P = 0.009; anti-TPO plus anti-TG antibodies,P = 0.04) and UI (anti-TPO, P = 0.002; anti-TG, P = 0.019; anti-TPO plus anti-TG antibodies, P = 0.005) was significantly increased in comparison to those with RSA. There was also a trend towards a higher prevalence of thyroid autoimmunity in the UI and IF groups than in the control group. TSH and free thyroxine levels all remained within a normal range. When embryo aneuploidy is ruled out, thrombophilia could constitute an etiologic factor in IF. Furthermore, thyroid autoimmunity is strongly related to UI and IF.
- 10 December 2007
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 23 (2) , 278-284
Open AccessThe role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion
The role of thrombophilia and thyroid autoimmunity in unexplained infertility (UI), implantation failure (IF) and recurrent spontaneous abortion (RSA) is controversial and poorly understood. From March, 2004 to January, 2007, 119 women were prospectively included: 32 oocyte donors, 31 patients with UI, 26 with IF and 30 with RSA. The IF and RSA groups presented normal preimplantation genetic screening. Protein C, protein S, antithrombin III, lupus anticoagulant, activated protein C resistance (APCR), immunoglobulin M and G anticardiolipin antibodies, homocystine, Factor V Leiden, prothrombin G20210A mutation, methylentetrahydrofolate reductase C677T mutation, thyroid-stimulating hormone (TSH), free thyroxine, anti-thyroid peroxidase (TPO) and anti-thyroglobulin (TG) antibodies were assessed. The prevalence of thrombophilia was high and similar among groups. In the IF group, the prevalence of APCR (15.4%), lupus anticoagulant (11.5%) and combined thrombophilia (19.2%) was higher, but not significantly different, than the other three groups. The prevalence of thyroid autoimmunity in women with IF (anti-TPO antibodies, P = 0.009; anti-TPO plus anti-TG antibodies,P = 0.04) and UI (anti-TPO, P = 0.002; anti-TG, P = 0.019; anti-TPO plus anti-TG antibodies, P = 0.005) was significantly increased in comparison to those with RSA. There was also a trend towards a higher prevalence of thyroid autoimmunity in the UI and IF groups than in the control group. TSH and free thyroxine levels all remained within a normal range. When embryo aneuploidy is ruled out, thrombophilia could constitute an etiologic factor in IF. Furthermore, thyroid autoimmunity is strongly related to UI and IF.